2021
DOI: 10.1590/0074-02760210207
|View full text |Cite
|
Sign up to set email alerts
|

Medicines for Malaria Venture COVID Box: a source for repurposing drugs with antifungal activity against human pathogenic fungi

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
14
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 47 publications
0
14
0
Order By: Relevance
“…The COVID Box was developed by the MMV in collaboration with scientists from industry and academia, to rapidly respond to the urgent need to combat COVID-19. As previously described, the COVID Box not only supports research against SARS-CoV-2, but also against other human threats [29,30]. However, this is the first study to evaluate the COVID Box against a human protozoan parasite.…”
Section: Discussionmentioning
confidence: 56%
“…The COVID Box was developed by the MMV in collaboration with scientists from industry and academia, to rapidly respond to the urgent need to combat COVID-19. As previously described, the COVID Box not only supports research against SARS-CoV-2, but also against other human threats [29,30]. However, this is the first study to evaluate the COVID Box against a human protozoan parasite.…”
Section: Discussionmentioning
confidence: 56%
“…Additionally, at least 14 non-antifungal drugs with potential activity against SARS-CoV-2 have shown in vitro antifungal activity against P . brasiliensis [ 18 ]. Therefore, this may also have contributed to protecting individuals against disease due to Paracoccidioides spp., which may perhaps explain, in part, the absence of post-COVID-19 PCM cases.…”
Section: Discussionmentioning
confidence: 99%
“…The patients from this study did not receive any drugs with known clinical activity against SARS-CoV-2, except favipravir, which does not have antifungal activity against Paracoccidioides spp. [ 18 ]…”
Section: Discussionmentioning
confidence: 99%
“…This approach gains particular significance in the current global context, with the world grappling with the COVID-19 pandemic, which has propelled the search for potent antiviral agents. Initiatives such as the COVID Box have surfaced in response to this pressing demand, offering a curated collection of 160 potential drug candidates ( Almeida-Paes et al, 2021 ). These compounds encompass a range of bioactivities, each demonstrating activity or suspected activity against SARS-CoV-2, the virus responsible for the ongoing pandemic.…”
Section: Introductionmentioning
confidence: 99%